India is the Focus Country at CPhI Worldwide Taking Place From the 9th Till the 11th of October 2012: IBEF

Oct 10, 2012, 06:13 ET from India Brand Equity Foundation (IBEF)

MADRID and GURGAON, India, October 10, 2012 /PRNewswire/ --

India Pavillion Inaugurated at CPhI Worldwide, Spain

Brand India Pharma is a significant initiative being led by Pharmaceutical Export Promotion Council (Pharmexcil) and India Brand Equity Foundation (IBEF) under the aegis of the Department of Commerce, Government of India, to highlight the value proposition that Brand India Pharma represents today for the global pharmaceutical industry.

     (Logo: )

"India is a powerhouse in the pharmaceutical sector and it is our pleasure to partner with India for this event. With 2,200 exhibitors from over 140 countries, CPhI Worldwide is a place where new partnerships are made and relations are strengthened. I would like to congratulate India to be the Focus Country for this event," said Mr Nik Rudge, Managing Director, UBM live.

"Given the huge size of India, it enables us to remain profitable and at the same time promote inclusive growth. It is a known fact that India is able to produce quality medicines at a very low cost," said Mr Sunil Lal, Ambassador of India to Spain.

Leading the Indian delegation, Mr S R Rao, Commerce Secretary, Ministry of Commerce and Industry, Government of India addressed the august gathering as the Chief Guest for the event. "India is already a world leader in generics and almost 2/3rd of these exports are to the highly regulated markets. As the world population is ageing, India is uniquely equipped to make most of this opportunity," said Mr S R Rao, Commerce Secretary, Ministry for Commerce and Industry, Government of India.

This was followed by the inauguration of the India Pavilion with lamp lighting at Hall 5, CPhI Worldwide, Feria De Madrid by Mr S R Rao, Mr Rajeev Kher, Mr J S Deepak, Mr Nik Rudge, Mr Sunil Lal, and Mr N R Munjal, Chairman, Pharmexcil.

Backed by a strong domestic market and vast presence in regulated markets like US and UK, the Brand India Pharma campaign is expected to expand the reach of the Indian pharmaceutical industry to new destinations and at the same time, strengthen its position in the already popular markets.

For more information on Events please visit

About India Brand Equity Foundation (IBEF):

India Brand Equity Foundation is a Trust established by the Ministry of Commerce with the Confederation of Indian Industry (CII) as its associate. IBEF's primary objective is to promote and create international awareness of the Made in India label in markets overseas and to facilitate the dissemination of knowledge of Indian products and services. IBEF is engaged in building Brand India. Towards this objective, IBEF works closely with stakeholders across government and industry.

Primary Media Contact: Aditi Thakur,, 91-9818143259

Secondary Media Contact: Pawan Chabra,, 91-124-4499609

SOURCE India Brand Equity Foundation (IBEF)